Dishman Carbogen Amcis Limited (DCAL) - Total Assets

Latest as of September 2025: Rs111.09 Billion INR ≈ $1.20 Billion USD

Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) holds total assets worth Rs111.09 Billion INR (≈ $1.20 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Dishman Carbogen Amcis Limited (DCAL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Dishman Carbogen Amcis Limited - Total Assets Trend (2005–2025)

This chart illustrates how Dishman Carbogen Amcis Limited's total assets have evolved over time, based on quarterly financial data. Explore DCAL strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Dishman Carbogen Amcis Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Dishman Carbogen Amcis Limited's total assets of Rs111.09 Billion consist of 22.0% current assets and 78.0% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs100.00 Million	5.1%
Accounts Receivable	Rs6.69 Billion	6.7%
Inventory	Rs9.00 Billion	9.0%
Property, Plant & Equipment	Rs31.71 Billion	31.7%
Intangible Assets	Rs2.93 Billion	2.9%
Goodwill	Rs40.54 Billion	40.5%

Asset Composition Trend (2005–2025)

This chart illustrates how Dishman Carbogen Amcis Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Dishman Carbogen Amcis Limited market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Dishman Carbogen Amcis Limited's current assets represent 22.0% of total assets in 2025, a decrease from 57.5% in 2005.
Cash Position: Cash and equivalents constituted 5.1% of total assets in 2025, up from 2.5% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 0.0% in 2005.
Asset Diversification: The largest asset category is goodwill at 40.5% of total assets.

Dishman Carbogen Amcis Limited Competitors by Total Assets

Key competitors of Dishman Carbogen Amcis Limited based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$8.59 Billion
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	USA	$4.40K
Krystal Biotech Inc NASDAQ:KRYS	USA	$1.40 Billion
Verona Pharma PLC ADR NASDAQ:VRNA	USA	$572.87 Million
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	USA	$641.76 Million
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Hebei Changshan Biochem Pharma SHE:300255	China	CN¥4.66 Billion
BB Biotech AG SW:BION	Switzerland	CHF2.64 Billion

Dishman Carbogen Amcis Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.10	1.04	1.14
Quick Ratio	0.64	0.60	0.75
Cash Ratio	0.28	0.19	0.00
Working Capital	Rs2.25 Billion	Rs773.10 Million	Rs2.15 Billion

Dishman Carbogen Amcis Limited - Advanced Valuation Insights

This section examines the relationship between Dishman Carbogen Amcis Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.47
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	4.4%
Total Assets	Rs99.99 Billion
Market Capitalization	$284.60 Million USD

Valuation Analysis

Below Book Valuation: The market values Dishman Carbogen Amcis Limited's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Dishman Carbogen Amcis Limited's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Dishman Carbogen Amcis Limited (2005–2025)

The table below shows the annual total assets of Dishman Carbogen Amcis Limited from 2005 to 2025.

Year	Total Assets	Change
2025-03-31	Rs99.99 Billion ≈ $1.08 Billion	+4.36%
2024-03-31	Rs95.81 Billion ≈ $1.04 Billion	+1.35%
2023-03-31	Rs94.53 Billion ≈ $1.02 Billion	+9.45%
2022-03-31	Rs86.37 Billion ≈ $934.11 Million	+3.24%
2021-03-31	Rs83.66 Billion ≈ $904.76 Million	+2.03%
2020-03-31	Rs82.00 Billion ≈ $886.78 Million	+11.89%
2019-03-31	Rs73.28 Billion ≈ $792.55 Million	+2.12%
2018-03-31	Rs71.76 Billion ≈ $776.11 Million	+8.84%
2017-03-31	Rs65.93 Billion ≈ $713.05 Million	+121.22%
2016-03-31	Rs29.81 Billion ≈ $322.33 Million	+5.96%
2015-03-31	Rs28.13 Billion ≈ $304.22 Million	+9.07%
2014-03-31	Rs25.79 Billion ≈ $278.92 Million	+11.41%
2013-03-31	Rs23.15 Billion ≈ $250.35 Million	+2.93%
2012-03-31	Rs22.49 Billion ≈ $243.22 Million	+8.00%
2011-03-31	Rs20.82 Billion ≈ $225.19 Million	+16.18%
2010-03-31	Rs17.92 Billion ≈ $193.83 Million	+6.11%
2009-03-31	Rs16.89 Billion ≈ $182.68 Million	+14.94%
2008-03-31	Rs14.70 Billion ≈ $158.94 Million	+26.60%
2007-03-31	Rs11.61 Billion ≈ $125.54 Million	+94.91%
2006-03-31	Rs5.96 Billion ≈ $64.41 Million	+84.86%
2005-03-31	Rs3.22 Billion ≈ $34.84 Million	--

About Dishman Carbogen Amcis Limited

NSE:DCAL India Biotechnology

Market Cap

$284.60 Million

Rs26.32 Billion INR

Market Cap Rank

#15191 Global

#760 in India

Share Price

Rs167.85

Change (1 day)

-4.71%

52-Week Range

Rs129.97 - Rs314.40

All Time High

Rs389.62